SAN DIEGO, Sept. 23, 2019 /PRNewswire/ -- NuVasive,
Inc. (NASDAQ: NUVA), the leader in spine technology innovation,
focused on transforming spine surgery with minimally disruptive,
procedurally integrated solutions, today announced its LessRay®
radiation reduction and workflow enhancement platform won the 2019
Spine Technology Award presented by Orthopedics This Week, a
widely read publication in the orthopedics industry. The Spine
Technology Award recognizes the best new spine technologies,
engineering teams and inventors for 2019 and rewards excellence in
innovation.
The 2019 Spine Technology Award is the third honor the LessRay
platform has achieved in 2019; the platform was voted a gold winner
in the Advanced Surgical Instruments category at the 2019 Edison
Awards™, as well as in the Radiological, Imaging and
Electromechanical Devices category at the 2019 Medical Design
Excellence Awards.
"LessRay is a surgical solution that truly makes the operating
room a safer place for patients, surgeons and their staff," said
Matt Link, president of NuVasive.
"Designed to maintain diagnostic image quality and anatomic
visualization with less radiation exposure, LessRay helps surgeons
perform minimally invasive surgical techniques which can lead to
reduced blood loss, shorter hospital stays and less operative
morbidity compared to open spine surgery."
The LessRay system is composed of a propriety software
algorithm and hardware components that help address overexposure to
radiation in hospital operating rooms (OR), particularly in the
case of minimally invasive spine surgery. Studies show spine
and orthopedic surgeons can receive their lifetime radiation limit
within the first 10 years of their career; LessRay has the ability
to reduce radiation emissions by up to 80 percent compared to
standard fluoroscopy.1 LessRay's proprietary image
enhancement technology improves low-dose, low-radiation fluoroscopy
images to have similar diagnostic capabilities as conventional
full-dose fluoroscopy images, thereby reducing radiation emission
and exposure in the OR. Additionally, LessRay's other features help
reduce the number of fluoroscopic shots needed and ultimately
decrease overall radiation exposure further. These features
include:
- C-arm tracking: Simplifies localization and helps
navigate to the targeted anatomy quickly and accurately with
reduced fluoroscopy time and unnecessary scouting images.
- Image stitching: Minimizes surgical workflow
interruption by quickly stitching together fluoroscopic images of
any spine segment.
- Angle finder: Minimizes OR steps required to obtain
crisp endplate shots with fewer fluoroscopic images than
traditional C-arm scouting.
- Alternate view: Improves visualization by making
metal instruments invisible or semi-transparent by fading out their
obstruction.
- Integrated Global Alignment® (iGA®): Measures spinal
alignment parameters directly on LessRay's user interface, enabling
quick access to long films for measuring alignment across multiple
levels.
NuVasive is integrating LessRay with its Pulse® platform, the
first and only single platform to include multiple technologies
designed to help surgeons adopt more efficient, less disruptive
surgical approaches in all spine procedures. The Pulse platform
combines multiple enabling technologies to improve workflow, reduce
variability and increase the reproducibility of surgical outcomes,
including neuromonitoring, surgical planning, rod bending,
radiation reduction, imaging and navigation
functions.2 The utility of the Pulse platform
currently rivals all competitive systems on the market, addressing
a broader range of clinical challenges in the OR.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology
innovation, focused on transforming spine surgery and beyond with
minimally disruptive, procedurally integrated solutions designed to
deliver reproducible and clinically-proven surgical outcomes. The
Company's portfolio includes access instruments, implantable
hardware, biologics, software systems for surgical planning,
navigation and imaging solutions, magnetically adjustable implant
systems for spine and orthopedics, and intraoperative monitoring
service offerings. With more than $1
billion in revenues, NuVasive has approximately 2,600
employees and operates in more than 50 countries serving surgeons,
hospitals and patients. For more information, please visit
www.nuvasive.com.
Forward-Looking Statements
NuVasive cautions you that statements included in this news release
that are not a description of historical facts are forward-looking
statements that involve risks, uncertainties, assumptions and other
factors which, if they do not materialize or prove correct, could
cause NuVasive's results to differ materially from historical
results or those expressed or implied by such forward-looking
statements. The potential risks and uncertainties which contribute
to the uncertain nature of these statements include, among others,
risks associated with acceptance of the Company's surgical products
and procedures by spine surgeons, development and acceptance of new
products or product enhancements, clinical and statistical
verification of the benefits achieved via the use of NuVasive's
products (including the iGA platform), the Company's ability to
effectually manage inventory as it continues to release new
products, its ability to recruit and retain management and key
personnel, and the other risks and uncertainties described in
NuVasive's news releases and periodic filings with the Securities
and Exchange Commission. NuVasive's public filings with the
Securities and Exchange Commission are available at www.sec.gov.
NuVasive assumes no obligation to update any forward-looking
statement to reflect events or circumstances arising after the date
on which it was made.
1 Wang TY, Farber SH, Perkins SS, et
al. An internally randomized control trial of radiation
exposure using ultra-low radiation imaging (ULRI) versus
traditional C-arm fluoroscopy for patients undergoing single-level
minimally invasive transforaminal lumbar interbody fusion. Spine
2017;42(4);217-23.
2 Certain applications of the Pulse platform
are under development and not available for commercial
sale.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/nuvasive-lessray-platform-wins-2019-spine-technology-award-from-orthopedics-this-week-300923415.html
SOURCE NuVasive, Inc.